We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+23.92%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$238M
AUM Growth
+$30.8M
Cap. Flow
+$7.19M
Cap. Flow %
3.03%
Top 10 Hldgs %
44.18%
Holding
90
New
31
Increased
11
Reduced
13
Closed
28

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$17.6M
2
AGN
Allergan plc
AGN
+$7.13M
3
RARE icon
Ultragenyx Pharmaceutical
RARE
+$6.94M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$6.03M
5
ESRX
Express Scripts Holding Company
ESRX
+$5.03M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$13.6M
2
MDT icon
Medtronic
MDT
+$9.03M
3
RCPT
RECEPTOS INC COM STK (DE)
RCPT
+$6.13M
4
VTRS icon
Viatris
VTRS
+$5.64M
5
AMGN icon
Amgen
AMGN
+$5.58M

Sector Composition

Rank Sector Weight
1 Healthcare 81.93%
2 Real Estate 0.91%
3 Technology 0.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVDQ
26
DELISTED
Novadaq Technologies Inc.
NVDQ
$3.25M 1.37%
200,000
+25,000
+14% +$372K
MDVN
27
DELISTED
MEDIVATION, INC.
MDVN
$3.23M 1.36%
+50,000
New +$2.86M
PETX
28
DELISTED
Aratana Therapeutics, Inc.
PETX
$3.2M 1.35%
200,000
+20,000
+11% +$356K
ELV icon
29
Elevance Health
ELV
$84.7B
$3.09M 1.3%
+20,000
New +$2.85M
MRK icon
30
Merck
MRK
$322B
$2.87M 1.21%
52,400
-26,200
-33% -$1.48M
CLDX icon
31
Celldex Therapeutics
CLDX
$3.48B
$2.79M 1.17%
6,667
– –
TTPH
32
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$2.75M 1.16%
+3,750
New +$2.82M
LGND icon
33
Ligand Pharmaceuticals
LGND
$5.76B
$2.7M 1.14%
+56,105
New +$2.15M
WMGI
34
DELISTED
Wright Medical Group Inc
WMGI
$2.58M 1.09%
100,000
-15,000
-13% -$386K
DYAX
35
DELISTED
DYAX CORPORATION
DYAX
$2.51M 1.06%
150,000
-25,000
-14% -$389K
ABBV icon
36
AbbVie
ABBV
$442B
$2.32M 0.97%
50,000
-25,000
-33% -$1.51M
ABT icon
37
Abbott
ABT
$190B
$2.32M 0.97%
+50,000
New +$2.3M
AVDL
38
DELISTED
Avadel Pharmaceuticals
AVDL
$2.25M 0.95%
+125,000
New +$1.96M
DOC icon
39
Healthpeak Properties
DOC
$14.1B
$2.16M 0.91%
+54,900
New +$2.2M
IMDZ
40
DELISTED
Immune Design Corp.
IMDZ
$2.11M 0.89%
+100,000
New +$2.61M
ASMB icon
41
Assembly Biosciences
ASMB
$540M
$1.99M 0.84%
12,500
+8,333
+200% +$1.13M
NBIX icon
42
Neurocrine Biosciences
NBIX
$16.5B
$1.99M 0.84%
+50,000
New +$1.79M
SPNC
43
DELISTED
Spectranetics Corp
SPNC
$1.74M 0.73%
50,000
– –
IPCM
44
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
$1.63M 0.69%
+35,000
New +$1.53M
CSLT
45
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$1.55M 0.65%
+200,000
New +$1.71M
PTCT icon
46
PTC Therapeutics
PTCT
$6.15B
$1.52M 0.64%
+25,000
New +$1.53M
ETRM
47
DELISTED
EnteroMedics Inc.
ETRM
$1.32M 0.56%
1,375
-953
-41% -$1.15M
DERM
48
DELISTED
Dermira, Inc.
DERM
$1.23M 0.52%
80,000
+30,000
+60% +$504K
TXMD icon
49
TherapeuticsMD
TXMD
$24M
$1.21M 0.51%
+4,000
New +$976K
KND
50
DELISTED
Kindred Healthcare
KND
$1.19M 0.5%
+50,000
New +$1.01M
1
2
3 4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q1 2015 Portfolio in Review

As of Q1 2015, Iguana Healthcare Management held 90 positions worth $238M, up 15% from $207M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Iguana Healthcare Management deployed $7.19M of net new capital in Q1 2015, opening 31 new positions and adding to 11 existing holdings. Its largest new stake was Allergan plc: 25,000 shares worth $7.44M.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, up from 71% a quarter earlier, followed by Real Estate and Technology.

On the sell side, the largest reduction was Gilead Sciences, an estimated $2.54M trimmed.

  • Iguana Healthcare Management's largest Q1 2015 buy was Allergan plc: 25,000 shares worth $7.44M.
  • Iguana Healthcare Management added most to Pfizer in Q1 2015, an estimated $17.6M increase.
  • Iguana Healthcare Management's biggest Q1 2015 reduction was Gilead Sciences, cutting an estimated $2.54M.
  • Iguana Healthcare Management fully exited Biogen in Q1 2015, selling an estimated $13.6M.
  • Iguana Healthcare Management's ten largest holdings make up 44% of its $238M portfolio in Q1 2015.
  • Iguana Healthcare Management opened 31 new positions and closed 28 in Q1 2015.
  • Iguana Healthcare Management's portfolio value rose 15% quarter-over-quarter to $238M.

Based on Iguana Healthcare Management's 13F filing for Q1 2015, filed 18 May 2015.